How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Sandare Chemical Co., Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
23 clearance records and 0 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Dec 4, 1979 to Sep 29, 1987.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| EAGLE DIAGNOSTICS GLYCOHEMOGLOBIN UNITIZED TESTK872852 · LCP | Sandare Chemical Co., Inc. | 510(k) | Sep 29, 1987FDA decision date |
| SANDARE GLYCOHEMOGLOBIN PROCEDUREK862556 · LCP | Sandare Chemical Co., Inc. | 510(k) | Aug 8, 1986FDA decision date |
| SANDARE BCG ALBUMIN PROCEDUREK860684 · CIX | Sandare Chemical Co., Inc. | 510(k) | Mar 17, 1986FDA decision date |
| SANDARE IRON-BINDING CAPACITY PROCEDUREK851395 · JMO | Sandare Chemical Co., Inc. | 510(k) | May 7, 1985FDA decision date |
| SANDARE IRON PROCEDUREK851394 · JIY | Sandare Chemical Co., Inc. | 510(k) | Apr 30, 1985FDA decision date |
| SANDARE ALKALINE PHOSPHATASE PROCEDUREK844498 · CIO | Sandare Chemical Co., Inc. | 510(k) | Dec 10, 1984FDA decision date |
| SANDARE ACID PHOSPHATASE PROCEDUREK842516 · CJR | Sandare Chemical Co., Inc. | 510(k) | Aug 17, 1984FDA decision date |
| TRI-LEVEL BILIRUBIN CONTROLSK833898 · JJX | Sandare Chemical Co., Inc. | 510(k) | Jan 13, 1984FDA decision date |
| TOTAL & DIRECT BILIRUBIN PROCEDURESK832942 · CIG | Sandare Chemical Co., Inc. | 510(k) | Nov 7, 1983FDA decision date |
| ALBUMIN PROCEDURE BCPK832632 · CJW | Sandare Chemical Co., Inc. | 510(k) | Sep 12, 1983FDA decision date |
| SANDARE CALCIUM PROCEDUREK832183 · CIC | Sandare Chemical Co., Inc. | 510(k) | Aug 24, 1983FDA decision date |
| TOTAL PROTEIN PROCEDUREK832169 · CEK | Sandare Chemical Co., Inc. | 510(k) | Aug 16, 1983FDA decision date |
| SANDARE FAST 340 PHOSPHORUS PROCEDUREK812670 · CED | Sandare Chemical Co., Inc. | 510(k) | Oct 2, 1981FDA decision date |
| SANDARE URIC ACID PROCEDUREK812313 · LFQ | Sandare Chemical Co., Inc. | 510(k) | Sep 1, 1981FDA decision date |
| SANDARE NITROPRUSSIDE TEST PROCEDUREK810514 · JLC | Sandare Chemical Co., Inc. | 510(k) | Mar 4, 1981FDA decision date |
| SANDARE GLYCOHEMOGLOBIN PROCEDUREK802832 · LCP | Sandare Chemical Co., Inc. | 510(k) | Jan 16, 1981FDA decision date |
| SANDARE LYOPHILIZED GLYCOHEMOGLOBIN CLS.K801422 · LCP | Sandare Chemical Co., Inc. | 510(k) | Jul 8, 1980FDA decision date |
| SANDARE LYOPHILIZED HEMOGLOBIN CONTROLSK800780 · JPK | Sandare Chemical Co., Inc. | 510(k) | Apr 24, 1980FDA decision date |
| SANDARE FAST 340 PHOSPHOROUS PROCEDUREK800297 · CEO | Sandare Chemical Co., Inc. | 510(k) | Mar 5, 1980FDA decision date |
| SANDARE CHLORIDE PROCEDUREK792531 · CHJ | Sandare Chemical Co., Inc. | 510(k) | Jan 11, 1980FDA decision date |
| SANDARE CYANMETHEMOGLOBIN STANDARDK792358 · KRZ | Sandare Chemical Co., Inc. | 510(k) | Dec 31, 1979FDA decision date |
| SANDARE CYANMETHEMOGLOBIN REAGENTK792503 · KHG | Sandare Chemical Co., Inc. | 510(k) | Dec 31, 1979FDA decision date |
| SANDARE HEMOGLOBIN CONTROLSK792209 · JPK | Sandare Chemical Co., Inc. | 510(k) | Dec 4, 1979FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.